Use of inflammatory modulators in the treatment of chronic or recalcitrant skin damage

摘要

The invention relates to the treatment chronic or recalcitrant skin damage such as leg ulceration. This is a difficult medical problem which requires a significant amount of health care resources. The invention seeks to mitigate the problem by the use of an agent which modulates the inflammatory activation of blood platelets such as a thromboxane receptor antagonist in an oral or topical formulation.